The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

Share Price Information for CATCo (CAT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 13.00
Ask: 35.00
Change: 0.00 (0.00%)
Spread: 22.00 (169.231%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
CAT Live PriceLast checked at -
CATCo Reinsurance Opportunities is an Investment Trust

To provide investors with significant capital returns and long-term distributions by making investments linked to catastrophe reinsurance risks via a variety of insurance-based investments.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Scheme of arrangement - Closing Date

29 Mar 2022 07:00

RNS Number : 3092G
CATCo Reinsurance Opps Fund Ltd
29 March 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION UNDER THE RETAINED UK LAW VERSION OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014 PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019 (SI 2019/310).

 

CATCo Reinsurance Opportunities Fund Ltd. (provisional liquidators appointed for restructuring purposes) (the Public Fund)

 

Completion of Buy-Out Transaction

 

Payment of Early Consent Fee

 

Partial Compulsory Redemption of Shares

 

London, 29 March 2022 - Further to previous announcements regarding the Buy-Out Transaction, Markel CATCo Reinsurance Fund Ltd. (provisional liquidators appointed for restructuring purposes) (the Private Fund), the Public Fund (together with the Private Fund, the Funds), and Markel CATCo Investment Management Ltd (provisional liquidators appointed for restructuring purposes) (MCIM) are pleased to provide the following update in relation to the completion of the Buy-Out Transaction.

Closing Date of the Schemes of Arrangement

Following the completion of the applicable conditions precedent, the Closing Date of the Schemes of Arrangement (the Schemes) to implement the Buy-Out Transaction occurred on 28 March 2022.

On the Closing Date, the Deed of Release became effective and binding on all Scheme Creditors. The Private Fund has initiated distributions to investors in accordance with the Schemes of Arrangement.

Early Consent Fee

The Public Fund expects that the Early Consent Fee payable to holders of Public Fund Shares will be paid on or about 30 March 2022. The Early Consent Fee will be payable through CREST to the accounts of holders of shares that issued a valid Transfer to Escrow Instruction, irrespective of whether such accounts continue to hold Public Fund Shares.

The Early Consent Fee to be paid per Share is:

· Early Consent Fee per Ordinary Share: $0.00676446

· Early Consent Fee per C Share: $0.01347267

Public Fund Scheme Distributions - Compulsory Redemption

Following the Closing Date, the Public Fund will proceed with the Public Fund Scheme Distributions as described in the Explanatory Statement dated 18 February 2022. The Public Fund Scheme Distributions will be made by way of compulsory partial redemption of up to 147,812,135 Ordinary Shares and 82,398,162 C Shares and on 6 April 2022 (the Public Fund Distribution Record Date, as defined in the Public Fund Scheme). 99% of the total issued share capital of the Public Fund (consisting of 99% of the C Shares and 99% of the Ordinary Shares) will be redeemed.

The redemption will be effected pro rata to holdings of Ordinary Shares and C Shares respectively on the register at the close of business on the Public Fund Distribution Record Date (6 April 2022). As at today's date, the Public Fund has 149,305,187 Ordinary Shares and 83,230,467 C Shares in issue.

The Public Fund Distribution will comprise:

· A total return of approximately USD 51,727,869 to holders of Ordinary Shares; and

· A total return of approximately USD 53,856,768 to holders of C Shares.

On account of the redemption of 99% of their holdings, shareholders will receive an amount equivalent to approximately USD 0.3465 per Ordinary Share held and USD 0.6471 per C Share held, calculated on the basis of 100% of their outstanding Shares. For example, a holder of 100 Ordinary Shares will receive payment of approximately USD 34.65 in consideration for the redemption of 99 Ordinary Shares and will be left with one Ordinary Share.

Fractions of Ordinary Shares and C Shares will not be redeemed and so the number of Ordinary Shares and C Shares to be redeemed for each shareholder will be rounded down to the nearest whole number (with a minimum of 1 share) of Ordinary Shares and C Shares, as appropriate.

All Ordinary Shares and C Shares that are redeemed will be cancelled with effect from the Public Fund Distribution Record Date. Accordingly, once redeemed, Ordinary Shares and C Shares will be incapable of transfer.

The Ordinary Shares and C Shares will be disabled in CREST after close of business on the Public Fund Distribution Record Date, and the existing ISIN numbers BMG1961Q2905 for the Ordinary Shares and BMG1961Q3085 for the C Shares (the Old ISINs) will expire.

The new ISIN numbers, which are BMG1961Q4075 in respect of the Ordinary Shares and BMG1961Q5064 in respect of the remaining C Shares which have not been redeemed (the New ISINs) will be enabled and available for transaction from and including 7 April 2022.

Up to and including the Public Fund Distribution Record Date, Ordinary Shares and C Shares will continue to be traded under the Old ISINs and as such, a purchaser of such Ordinary Shares or C Shares, as the case may be, would have a market claim for a proportion of the redemption proceeds. CREST will automatically transform any open transaction as at the Public Fund Distribution Record Date into the New ISINs.

Shareholders should note that the Board retains absolute discretion as to the execution, extent and timing of any further returns of capital.

Expected table for redemption:

Announcement of redemption notice

29 March 2022

Public Fund Distribution Record Date

6 April 2022

Redemption date and expiry of old ISINs

6 April 2022

Ex date and new ISINs enabled

7 April 2022

Public Fund Scheme Distribution paid to uncertificated holdings

11 April 2022

Public Fund Scheme Distribution paid to certificated holdings

11 April 2022

Capitalised terms used but not defined in this announcement have the meaning given to them in the Explanatory Statement. The Explanatory Statement and other details of the Schemes are available on the Scheme Website at https://catcobuyout.alixpartners.com.

 

The person responsible for arranging release of this announcement is: Judith Wynne, General Counsel, MCIM.

 

For Further Information:

 

 

Markel CATCo Investment Management Ltd

 

Judith Wynne

General Counsel

Telephone: +1 441 493 9005

Email: judith.wynne@markelcatco.com

 

 

Numis Securities Limited

 

Hugh Jonathan

Telephone +44 (0) 20 7260 1000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SOABCGDXLDDDGDI
Date   Source Headline
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)
7th Mar 20227:00 amRNSScheme of arrangement -Sanction Hearing & Timeline
28th Feb 20227:00 amRNSScheme of arrangement - Voting deadline 1 March
24th Feb 20227:00 amRNSScheme of arrangement - US Bankruptcy Court
18th Feb 20223:04 pmRNSScheme of arrangement - Notices of Scheme Meetings
17th Feb 20227:00 amRNSScheme of arrangement - Convening Order
14th Feb 20225:31 pmRNSScheme of arrangement - Directions Hearing
11th Feb 20227:00 amRNSScheme of arrangement - Amendment of Undertakings
7th Feb 20227:00 amRNSNet Asset Value(s)
4th Feb 20227:00 amRNSScheme of arrangement - improved terms
23rd Dec 20217:00 amRNSNet Asset Value(s)
13th Dec 20212:00 pmRNSScheme of arrangement - Update
10th Dec 20217:00 amRNSScheme of arrangement - Update
18th Nov 20211:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.